These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
305 related items for PubMed ID: 17653716
1. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin. Kawano H, Komaba S, Yamasaki T, Maeda M, Kimura Y, Maeda A, Kaneda Y. Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716 [Abstract] [Full Text] [Related]
2. A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy. Kawano H, Komaba S, Kanamori T, Kaneda Y. BMC Med; 2007 Sep 21; 5():28. PubMed ID: 17883878 [Abstract] [Full Text] [Related]
3. Interleukin-12 immunotherapy of murine transitional cell carcinoma of the bladder: dose dependent tumor eradication and generation of protective immunity. O'Donnell MA, Luo Y, Hunter SE, Chen X, Hayes LL, Clinton SK. J Urol; 2004 Mar 21; 171(3):1330-5. PubMed ID: 14767343 [Abstract] [Full Text] [Related]
4. Nonviral cytokine gene therapy on an orthotopic bladder cancer model. Wu Q, Mahendran R, Esuvaranathan K. Clin Cancer Res; 2003 Oct 01; 9(12):4522-8. PubMed ID: 14555526 [Abstract] [Full Text] [Related]
5. Effects of vitamin D (calcitriol) on transitional cell carcinoma of the bladder in vitro and in vivo. Konety BR, Lavelle JP, Pirtskalaishvili G, Dhir R, Meyers SA, Nguyen TS, Hershberger P, Shurin MR, Johnson CS, Trump DL, Zeidel ML, Getzenberg RH. J Urol; 2001 Jan 01; 165(1):253-8. PubMed ID: 11125420 [Abstract] [Full Text] [Related]
6. Intravesical therapy with vinorelbine tartrate: antitumor activity in orthotopic murine cell carcinoma of the bladder. Bonfil RD, Russo DM, Schmilovich AJ, Garcia-Palazzo IB. J Urol; 1997 Sep 01; 158(3 Pt 1):912-5. PubMed ID: 9258118 [Abstract] [Full Text] [Related]
7. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept. Laihia JK, Pylkkänen L, Laato M, Boström PJ, Leino L. BJU Int; 2009 Nov 01; 104(9):1233-8. PubMed ID: 19466948 [Abstract] [Full Text] [Related]
8. Therapeutic efficacy and microSPECT/CT imaging of 188Re-DXR-liposome in a C26 murine colon carcinoma solid tumor model. Chang YJ, Chang CH, Yu CY, Chang TJ, Chen LC, Chen MH, Lee TW, Ting G. Nucl Med Biol; 2010 Jan 01; 37(1):95-104. PubMed ID: 20122674 [Abstract] [Full Text] [Related]
9. The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer. Zhang Z, Xu X, Zhang X, Chen X, Chen Q, Dong L, Hu Z, Li J, Gao J. Acta Oncol; 2011 Oct 01; 50(7):1111-8. PubMed ID: 21247263 [Abstract] [Full Text] [Related]
13. [A simple and efficient method for establishing a mouse model of orthotopic MB49 bladder cancer]. Liang ZK, Zhang L, Hu ZM, Chen Z, Huang X, Shi XH, Tan WL, Gao JM. Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr 01; 29(4):627-30. PubMed ID: 19403380 [Abstract] [Full Text] [Related]
16. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer. Hadaschik BA, ter Borg MG, Jackson J, Sowery RD, So AI, Burt HM, Gleave ME. BJU Int; 2008 Jun 01; 101(11):1347-55. PubMed ID: 18384637 [Abstract] [Full Text] [Related]
18. Magnetic resonance imaging of response to chemotherapy in orthotopic xenografts of human bladder cancer. Mazurchuk R, Glaves D, Raghavan D. Clin Cancer Res; 1997 Sep 01; 3(9):1635-41. PubMed ID: 9815854 [Abstract] [Full Text] [Related]
19. GFP image analysis in the mouse orthotopic bladder cancer model. De Velasco MA, Tanaka M, Anai S, Tomioka A, Nishio K, Uemura H. Oncol Rep; 2008 Sep 01; 20(3):543-7. PubMed ID: 18695904 [Abstract] [Full Text] [Related]
20. Significance of target cell infection and natural killer cells in the anti-tumor effects of bacillus Calmette-Guerin in murine bladder cancer. Sonoda T, Sugimura K, Ikemoto S, Kawashima H, Nakatani T. Oncol Rep; 2007 Jun 01; 17(6):1469-74. PubMed ID: 17487406 [Abstract] [Full Text] [Related] Page: [Next] [New Search]